CZ25398A3 - Farmaceutický prostředek - Google Patents
Farmaceutický prostředekInfo
- Publication number
- CZ25398A3 CZ25398A3 CZ98253A CZ25398A CZ25398A3 CZ 25398 A3 CZ25398 A3 CZ 25398A3 CZ 98253 A CZ98253 A CZ 98253A CZ 25398 A CZ25398 A CZ 25398A CZ 25398 A3 CZ25398 A3 CZ 25398A3
- Authority
- CZ
- Czechia
- Prior art keywords
- pharmaceutical preparation
- prodrug
- hydrate
- compound
- formula
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
- 239000001569 carbon dioxide Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1851896P | 1996-05-28 | 1996-05-28 | |
| GBGB9612668.5A GB9612668D0 (en) | 1996-06-18 | 1996-06-18 | Carbapenem antibiotic composition and method of preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ25398A3 true CZ25398A3 (cs) | 1998-07-15 |
| CZ296381B6 CZ296381B6 (cs) | 2006-03-15 |
Family
ID=26309530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ0025398A CZ296381B6 (cs) | 1996-05-28 | 1997-05-23 | Farmaceutický prostredek |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP0863901B1 (cs) |
| JP (2) | JPH11509871A (cs) |
| KR (2) | KR100403497B1 (cs) |
| CN (1) | CN1067074C (cs) |
| AT (1) | ATE252584T1 (cs) |
| AU (1) | AU710102B2 (cs) |
| BG (1) | BG63821B1 (cs) |
| CA (1) | CA2227994C (cs) |
| CO (1) | CO4940412A1 (cs) |
| CY (1) | CY2437B1 (cs) |
| CZ (1) | CZ296381B6 (cs) |
| DE (1) | DE69725696T2 (cs) |
| DK (1) | DK0863901T3 (cs) |
| DZ (1) | DZ2242A1 (cs) |
| EA (1) | EA000534B1 (cs) |
| EE (1) | EE04678B1 (cs) |
| ES (1) | ES2208907T3 (cs) |
| HR (1) | HRP970281B1 (cs) |
| HU (1) | HU229426B1 (cs) |
| ID (1) | ID16974A (cs) |
| IL (1) | IL123078A (cs) |
| IS (1) | IS2353B (cs) |
| MX (1) | MX9800808A (cs) |
| NO (1) | NO323815B1 (cs) |
| NZ (1) | NZ329649A (cs) |
| PL (1) | PL188917B1 (cs) |
| PT (1) | PT863901E (cs) |
| RS (1) | RS49583B (cs) |
| SI (1) | SI0863901T1 (cs) |
| SK (1) | SK284359B6 (cs) |
| TR (1) | TR199800146T1 (cs) |
| TW (1) | TW434014B (cs) |
| WO (1) | WO1997045430A1 (cs) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2268820A1 (en) * | 1996-10-28 | 1998-05-07 | Merck & Co., Inc. | Stabilized carbapenem antibiotic compositions and method of making |
| NZ500955A (en) * | 1997-06-16 | 2001-06-29 | Merck & Co Inc | Stabilized 1-beta-methyl-carbapenem intermediates and synthetic use |
| US6180783B1 (en) * | 1997-06-16 | 2001-01-30 | Merck & Co., Inc. | Stabilized carbapenem intermediates and improved process for carbapenem synthesis |
| US6504027B1 (en) | 1998-03-02 | 2003-01-07 | Merck & Co., Inc. | Decarboxylation process for synthesizing carbapenem antibiotics |
| JP4854899B2 (ja) * | 1999-10-29 | 2012-01-18 | メルク・シャープ・エンド・ドーム・コーポレイション | カルバペネム系抗生物質組成物の処方方法 |
| AR035728A1 (es) | 2001-01-16 | 2004-07-07 | Merck & Co Inc | Proceso perfeccionado para la sintesis de carbapenem |
| CN101357918B (zh) * | 2007-06-22 | 2011-05-18 | 山东轩竹医药科技有限公司 | 含有异硫脲基巯基吡咯烷的培南衍生物 |
| CN101367815B (zh) * | 2007-06-28 | 2012-07-04 | 山东轩竹医药科技有限公司 | 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物 |
| WO2009075309A1 (ja) * | 2007-12-12 | 2009-06-18 | Dainippon Sumitomo Pharma Co., Ltd. | 製剤組成物 |
| CN101550138B (zh) * | 2008-04-03 | 2011-05-18 | 山东轩竹医药科技有限公司 | 巯基氮杂环烷酰胺醇取代的培南衍生物 |
| EP2505191A1 (en) * | 2008-06-11 | 2012-10-03 | Ranbaxy Laboratories Limited | Lyophilized Carbapenem antibiotic composition |
| EP2415758B1 (en) | 2009-03-31 | 2017-03-01 | Mitsubishi Materials Electronic Chemicals Co., Ltd. | Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound |
| CN102803649A (zh) | 2009-06-25 | 2012-11-28 | 国际壳牌研究有限公司 | 注水系统和方法 |
| US8889384B2 (en) | 2010-10-07 | 2014-11-18 | Shell Oil Company | Process for the production of alcohols from biomass |
| PL2635712T3 (pl) | 2010-11-05 | 2014-12-31 | Shell Int Research | Obróbka biomasy do wytworzenia materiałów użytecznych do biopaliw |
| WO2012088108A1 (en) | 2010-12-20 | 2012-06-28 | Shell Oil Company | Process for the production of alcohols from biomass |
| AU2012352235B2 (en) | 2011-12-15 | 2015-01-15 | Shell Internationale Research Maatschappij B.V. | Method of treating byproducts from ethanol production |
| WO2013173576A1 (en) | 2012-05-17 | 2013-11-21 | Shell Oil Company | Methods and systems for processing biomass material |
| CN103860485A (zh) * | 2012-12-18 | 2014-06-18 | 深圳市海滨制药有限公司 | 一种厄他培南钠冻干制剂及其制备方法 |
| EP3132045A1 (en) | 2014-04-17 | 2017-02-22 | Shell Internationale Research Maatschappij B.V. | Processes for producing fermentation products |
| RU2713660C2 (ru) | 2014-08-14 | 2020-02-06 | Шелл Интернэшнл Рисерч Маатсхаппий Б.В. | Способ получения фурфурола из биомасс |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES525492A0 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
| GB9202298D0 (en) * | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
| CA2091309A1 (en) * | 1992-03-26 | 1993-09-27 | Frederic H. Jung | Antibiotic compounds |
-
1997
- 1997-05-21 HR HR970281A patent/HRP970281B1/xx not_active IP Right Cessation
- 1997-05-23 HU HU9901567A patent/HU229426B1/hu unknown
- 1997-05-23 PL PL97324746A patent/PL188917B1/pl unknown
- 1997-05-23 EE EE9800022A patent/EE04678B1/xx unknown
- 1997-05-23 SI SI9730603T patent/SI0863901T1/xx unknown
- 1997-05-23 RS YUP-41/98A patent/RS49583B/sr unknown
- 1997-05-23 WO PCT/US1997/008831 patent/WO1997045430A1/en active IP Right Grant
- 1997-05-23 DE DE69725696T patent/DE69725696T2/de not_active Expired - Lifetime
- 1997-05-23 AU AU30775/97A patent/AU710102B2/en not_active Expired
- 1997-05-23 CN CN97190911A patent/CN1067074C/zh not_active Expired - Lifetime
- 1997-05-23 ES ES97925725T patent/ES2208907T3/es not_active Expired - Lifetime
- 1997-05-23 IL IL12307897A patent/IL123078A/en not_active IP Right Cessation
- 1997-05-23 MX MX9800808A patent/MX9800808A/es active IP Right Grant
- 1997-05-23 AT AT97925725T patent/ATE252584T1/de active
- 1997-05-23 KR KR10-2001-7008925A patent/KR100403497B1/ko not_active Expired - Lifetime
- 1997-05-23 TR TR1998/00146T patent/TR199800146T1/xx unknown
- 1997-05-23 JP JP9542800A patent/JPH11509871A/ja not_active Withdrawn
- 1997-05-23 EP EP97925725A patent/EP0863901B1/en not_active Expired - Lifetime
- 1997-05-23 NZ NZ329649A patent/NZ329649A/en not_active IP Right Cessation
- 1997-05-23 CA CA002227994A patent/CA2227994C/en not_active Expired - Lifetime
- 1997-05-23 EA EA199800180A patent/EA000534B1/ru not_active IP Right Cessation
- 1997-05-23 PT PT97925725T patent/PT863901E/pt unknown
- 1997-05-23 CZ CZ0025398A patent/CZ296381B6/cs not_active IP Right Cessation
- 1997-05-23 SK SK109-98A patent/SK284359B6/sk not_active IP Right Cessation
- 1997-05-23 DK DK97925725T patent/DK0863901T3/da active
- 1997-05-23 KR KR1019980700717A patent/KR100344479B1/ko not_active Expired - Lifetime
- 1997-05-26 CO CO97028781A patent/CO4940412A1/es unknown
- 1997-05-26 ID IDP971736A patent/ID16974A/id unknown
- 1997-05-27 DZ DZ970091A patent/DZ2242A1/fr active
- 1997-05-28 TW TW086107254A patent/TW434014B/zh not_active IP Right Cessation
-
1998
- 1998-01-27 IS IS4663A patent/IS2353B/is unknown
- 1998-01-28 NO NO19980380A patent/NO323815B1/no not_active IP Right Cessation
- 1998-02-24 BG BG102273A patent/BG63821B1/bg unknown
-
2004
- 2004-04-26 CY CY0400030A patent/CY2437B1/xx unknown
-
2008
- 2008-10-17 JP JP2008268213A patent/JP5255983B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ25398A3 (cs) | Farmaceutický prostředek | |
| MY132671A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
| WO2001042219A3 (en) | Novel substituted phenanthridinones and methods of use thereof | |
| WO1998028282A3 (en) | OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS | |
| HUP9903174A2 (hu) | Koenzim Q-10-et tartalmazó gyógyászati készítmény | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| AU3215597A (en) | Method of inhibiting fibrosis with a somatostatin agonist | |
| AU7535798A (en) | Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same | |
| YU41199A (sh) | Hinoksalindioni | |
| EP1057813A4 (en) | INDOLE DERIVATIVES AND MEDICAL COMPOSITIONS CONTAINING THEM | |
| UA29435C2 (uk) | Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі | |
| UA62920C2 (en) | Carbapeneme antibiotic, a composition and a method for the preparation | |
| AU5727899A (en) | Diaminocyclobutene-3,4-dione derivatives, their preparation and use | |
| BG105539A (en) | Eletriptan hydrobromide monohydrate | |
| CA2399709A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers | |
| BG106534A (en) | Oral solution containing galanthamine and a sweetening agent | |
| BG106151A (en) | Pharmaceutical complex | |
| WO2000002877A3 (en) | New pharmaceutically active compounds | |
| MY116202A (en) | Carbapenem antibiotic, composition and method of preparation | |
| ECSP972136A (es) | Composicion y metodo de preparacion de un antibiotico de carbapemen | |
| ZA968315B (en) | Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD00 | Pending as of 2000-06-30 in czech republic | ||
| MK4A | Patent expired |
Effective date: 20170523 |